NEW YORK (GenomeWeb) – British informatics firm Genomics plc today announced a collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust to analyze genomic sequences in rare diseases and cancer.

Under the terms of the agreement, the partners will work on a pilot study to establish genome sequencing as a clinical tool in rare diseases, cancers, and other disorders. Genomics will use its software to analyze up to 500 genome sequences, linking genotypes and phenotypes.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.